Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-017092
Filing Date
2020-09-01
Accepted
2020-09-01 16:34:50
Documents
1
Period of Report
2020-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 54572
  Complete submission text file 0001493152-20-017092.txt   55935
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36268 | Film No.: 201154805
SIC: 2835 In Vitro & In Vivo Diagnostic Substances